ALERISLIFE INC (ALR)

US33832D2053 - Common Stock

1.32  +0.01 (+0.76%)

Fundamental Rating

1

Taking everything into account, ALR scores 1 out of 10 in our fundamental rating. ALR was compared to 117 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ALR have multiple concerns. ALR has a expensive valuation and it also scores bad on growth.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALR had negative earnings in the past year.
In the past year ALR has reported a negative cash flow from operations.
ALR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALR reported negative operating cash flow in multiple years.

1.2 Ratios

ALR has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALR (17.07%) is worse than 67.54% of its industry peers.
In the last couple of years the Gross Margin of ALR has declined.
ALR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.79%
GM growth 5Y-27.35%

More info and screens

3

2. Health

2.1 Basic Checks

ALR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALR has been increased compared to 1 year ago.
ALR has a worse debt/assets ratio than last year.

2.2 Solvency

ALR has an Altman-Z score of 0.82. This is a bad value and indicates that ALR is not financially healthy and even has some risk of bankruptcy.
ALR has a Altman-Z score (0.82) which is comparable to the rest of the industry.
ALR has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
ALR has a Debt to Equity ratio of 0.45. This is in the better half of the industry: ALR outperforms 64.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACCN/A
WACC7.46%

2.3 Liquidity

A Current Ratio of 1.58 indicates that ALR should not have too much problems paying its short term obligations.
The Current ratio of ALR (1.58) is better than 62.28% of its industry peers.
ALR has a Quick Ratio of 1.58. This is a normal value and indicates that ALR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.58, ALR is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58

More info and screens

2

3. Growth

3.1 Past

ALR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.67%.
Looking at the last year, ALR shows a very negative growth in Revenue. The Revenue has decreased by -31.89% in the last year.
Measured over the past years, ALR shows a decrease in Revenue. The Revenue has been decreasing by -7.47% on average per year.
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-22.73%
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y-7.47%
Revenue growth Q2Q-19.12%

3.2 Future

The Earnings Per Share is expected to grow by 20.52% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALR will show a decrease in Revenue. The Revenue will decrease by -1.08% on average per year.
EPS Next Y-29.68%
EPS Next 2Y15.18%
EPS Next 3Y20.52%
EPS Next 5YN/A
Revenue Next Year-23.66%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.08%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ALR's earnings are expected to grow with 20.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3Y20.52%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALERISLIFE INC

NASDAQ:ALR (3/17/2023, 8:00:00 PM)

1.32

+0.01 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap44.18M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 17.07%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-29.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y